Bone glues are of two types – synthetic and natural bone glues. Synthetic bone glues considered in this report are cyanoacrylate, methacrylate, polyurethane foams, bisphenol-A glycidyl dimethacrylate, epoxy resins, and zinc polycarboxylate. Natural bone glues are biologically derived adhesives and sealants i.e. fibrin sealants and its variants. Other groups include gelatin-aldehydes, protein-aldehydes, collagen-based adhesives, polysaccharide-based adhesives, mussel adhesive proteins, and other biomimetic glues.
Europe gelatin and bone glue market is estimated to account for US$ 310.4 Mn in terms of value by the end of 2027.
Europe Gelatin and Bone Glue Market: Drivers
Increasing number of joint replacement procedures is expected to propel growth of Europe gelatin and bone glue market over the forecast period. For instance, according to National Joint Registry 15th Annual Report 2018, 252,250 joint replacements were performed in England, Wales, Northern Ireland and the Isle of Man, in 2018, accounting for 10,000 additional joint replacement operations than recorded in 2017.
Europe Gelatin and Bone Glue Market: Opportunities
R&D of novel bioceramics is expected to offer lucrative growth opportunities for players in market. For instance, in December 2018, researchers from Uppsala University, Sweden, reported development of a new class of bioinspired calcium phosphate cementsthat can glue tissues together and bond tissues to metallic and polymeric biomaterials.
Europe Gelatin and Bone Glue Market: Restraints
Stringent regulations for approval of new products and low efficiency of some gelatin and surgical sealants is expected to limit growth of the market. For instance, cyanoacrylate glues are suitable for most surgical procedures. However, they have not been yet cleared for inward application because of their toxicity.
Europe gelatin and bone glue market was valued at US$ 193.0 Mn in 2019 and is forecast to reach a value of US$ 310.4 Mn by 2027 at a CAGR of 6.1% between 2020 and 2027. Increasing adoption of expansion strategies from major players operating in the market is expected to assist the growth of the market.
Bone Glues segment held dominant position in Europe gelatin and bone glue market in 2019, accounting for 68.1% share in terms of value, followed by Gelatin, respectively. Increasing number of joint replacement procedures is expected to propel growth of the segment during the forecast period.
Arthroplasty segment held dominant position in Europe gelatin and bone glue market in 2019, accounting for 39.7% share in terms of value, followed by Sports Injury, respectively. Increasing prevalence of bone related disorders is expected to propel growth of the market during the forecasted period
Increasing number of ocular injuries is expected to boost growth of Europe gelatin and bone glue market. For instance, according to the study, “Ocular injuries caused by less-lethal weapons in France”, published in November 2019, in The Lancet, between February 2016 and August 2019, 43 cases of ocular injuries were identified in Paris.
In March 2019, Regen Lab challenged the European Patent Office’s disapproval for its patent for autologous biological glue earlier granted by British Court.
Europe Gelatin and Bone Glue Market: Competitive Landscape
Major players operating in include, Johnson & Johnson, Baxter International Inc., CryoLife, Inc., Becton, Dickinson and Company, Luna Innovations Incorporated, B. Braun Melsungen AG, Cohera Medical, Inc., Integra LifeSciences Corporation, Tissuemed Ltd., and Chemence Medical, Inc.
Europe Gelatin and Bone Glue Market: Key Developments
April 2019: CryoLife, Inc participated in the 18th Annual Needham Healthcare Conference in New York
Scope of the report